- Report
- February 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2025
- 262 Pages
Global
From €4361EUR$5,000USD£3,782GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2026
- 287 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 274 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 138 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 373 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 294 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 385 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 378 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 605 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- January 2026
- 122 Pages
Global
From €4143EUR$4,750USD£3,593GBP
- Report
- May 2025
- 114 Pages
Global
From €4143EUR$4,750USD£3,593GBP
- Report
- November 2025
- 160 Pages
Global
From €3445EUR$3,950USD£2,988GBP
- Report
- October 2025
- 160 Pages
Global
From €3445EUR$3,950USD£2,988GBP
- Report
- October 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,912GBP
€4230EUR$4,850USD£3,668GBP
- Report
- September 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,912GBP
€4230EUR$4,850USD£3,668GBP
- Report
- September 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,912GBP
€4230EUR$4,850USD£3,668GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more